SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PASQUINI, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.157
AS - Asia 1.473
EU - Europa 783
SA - Sud America 362
AF - Africa 33
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.818
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.072
SG - Singapore 628
CN - Cina 347
BR - Brasile 318
IT - Italia 295
HK - Hong Kong 140
DE - Germania 121
VN - Vietnam 102
GB - Regno Unito 73
ID - Indonesia 59
TR - Turchia 59
RU - Federazione Russa 52
CA - Canada 50
PL - Polonia 41
FR - Francia 36
FI - Finlandia 33
UA - Ucraina 32
IN - India 30
MX - Messico 25
AR - Argentina 21
SE - Svezia 19
TW - Taiwan 18
NL - Olanda 17
CH - Svizzera 15
JP - Giappone 15
ZA - Sudafrica 14
BD - Bangladesh 13
AT - Austria 10
PK - Pakistan 10
ES - Italia 9
IQ - Iraq 9
KR - Corea 8
AU - Australia 7
BE - Belgio 7
CO - Colombia 7
LT - Lituania 7
MA - Marocco 7
SA - Arabia Saudita 6
VE - Venezuela 5
EC - Ecuador 4
EG - Egitto 4
IR - Iran 4
KE - Kenya 4
CZ - Repubblica Ceca 3
IL - Israele 3
JO - Giordania 3
LV - Lettonia 3
MY - Malesia 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CL - Cile 2
EU - Europa 2
GE - Georgia 2
JM - Giamaica 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
KZ - Kazakistan 1
MK - Macedonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VG - Isole Vergini Britanniche 1
Totale 4.818
Salva come PNG Salva come JPEG
Città #
Ashburn 352
Singapore 340
Fairfield 165
Beijing 147
Hong Kong 138
Santa Clara 138
Woodbridge 107
Chandler 104
Houston 89
Los Angeles 86
Ferrara 81
Seattle 73
Munich 61
Cambridge 55
Jakarta 53
Wilmington 47
Dallas 42
New York 41
Warsaw 38
Ann Arbor 37
Milan 37
Ho Chi Minh City 35
Shanghai 31
São Paulo 30
Jacksonville 29
Izmir 28
Buffalo 27
Princeton 27
Bologna 24
Denver 23
London 21
Hanoi 18
Toronto 18
Turku 18
Hefei 15
Mexico City 15
Zurich 15
Chennai 14
Chicago 14
Frankfurt am Main 14
Orem 14
Taipei 14
Rio de Janeiro 13
Montreal 12
Tokyo 12
Nanjing 11
Ankara 10
Boston 10
Brooklyn 10
Manchester 10
Nuremberg 10
Phoenix 10
San Diego 10
San Francisco 10
Falls Church 9
Poplar 9
Venice 9
Atlanta 8
Council Bluffs 8
Ferrara di Monte Baldo 8
Johannesburg 8
Moscow 8
Nice 8
Tucson 8
Belo Horizonte 7
Boardman 7
Lauterbourg 7
San Antonio 7
Stockholm 7
Brussels 6
Curitiba 6
Nanchang 6
Ottawa 6
San Jose 6
The Dalles 6
Verona 6
Blumenau 5
Chattanooga 5
Florence 5
Genoa 5
Haiphong 5
Homburg 5
Istanbul 5
Porto Alegre 5
Redondo Beach 5
Ribeirão das Neves 5
Richardson 5
Salvador 5
Tianjin 5
Vercelli 5
Assago 4
Biên Hòa 4
Brasília 4
Cagliari 4
Campinas 4
Changsha 4
Charlotte 4
Columbus 4
Da Nang 4
Faisalabad 4
Totale 3.073
Salva come PNG Salva come JPEG
Nome #
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 229
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 221
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 213
The role of adenosinergic system in brain ischemia 197
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 195
Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists 179
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 171
Development of novel pyridazinone-based adenosine receptor ligands 165
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma 141
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists 132
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 123
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity 120
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic? 117
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 117
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 106
Adenosine and inflammation: Here, there and everywhere 104
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives 103
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment? 102
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes 98
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators 96
Effect of Low-Frequency, Low-Energy Pulsed Electromagnetic Fields in Neuronal and Microglial Cells Injured with Amyloid-Beta 96
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 95
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A1AR Positive Allosteric Modulation 93
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 90
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors 90
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer's Disease 88
Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic Implications 88
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients 86
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2A adenosine receptor antagonists/inverse agonists 86
Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents 85
Pharmacology of Adenosine Receptors: Recent Advancements 84
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 81
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents 80
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 80
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 79
Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor 78
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 75
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study 75
Pulsed electromagnetic fields stimulate hif-1α-independent vegf release in 1321n1 human astrocytes protecting neuron-like sh-sy5y cells from oxygen-glucose deprivation 75
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy 74
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications 70
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition 70
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy 68
Targeting adenosine receptors: A potential pharmacological avenue for acute and chronic pain 67
Piperazine-and piperidine-containing thiazolo[5,4-d]pyrimidine derivatives as new potent and selective adenosine a2a receptor inverse agonists 65
Totale 4.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021294 0 0 0 0 0 23 86 48 30 58 39 10
2021/2022228 10 14 13 0 5 17 27 20 16 18 44 44
2022/2023286 29 48 4 27 23 20 43 22 24 9 23 14
2023/2024235 17 14 9 6 38 13 11 24 7 13 10 73
2024/20251.440 39 62 116 58 127 149 104 88 226 163 170 138
2025/20261.927 372 186 307 460 568 34 0 0 0 0 0 0
Totale 4.947